AI ASSISTANT
Ask DrugCentral
Explore drug properties, targets, and indications with answers grounded in DrugCentral.
Powered by DrugCentral + retrieval-augmented AIYour question
Ask in your own words. Each question is answered independently.
Explore sample questions
Select a question to fill the editor, then ask it or make it your own.
DrugCentral answer
Your answer will appear here. Open linked drug cards in a new tab to explore the source details.
About Ask DrugCentral
Ask DrugCentral helps you explore drug properties, biological targets, and indications using natural language. Sample questions offer starting points, and linked drug cards let you check the underlying records.
General architecture
- Ask a questionThe browser sends your question to the same-origin Django chat API.
- Retrieve and generateThe API forwards the question to the configured DrugCentral retrieval-augmented generation (RAG) service, which returns an AI-generated answer.
- Explore the answerThe app resolves cited drug-card names and displays the answer with links to drug records.
Using the assistant
Each request is independent; previous questions are not sent as conversation history. You can edit a sample before submitting, retry a failed request, or switch back to normal search. Drug links open in a new tab so your question and answer stay available.
Answers may contain mistakes or omit information. Verify details against DrugCentral records and original sources.
AI can make mistakes. Verify answers against the original sources before relying on them.
capsaicin 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| analgesics, capsaicin analogues | 3064 | 404-86-4 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
An alkylamide found in CAPSICUM that acts at TRPV CATION CHANNELS.
Legend: OFP - off patent OFM - off market ONP - on patent |
Drug dosage:
None
ADMET properties:
| Property | Value | Reference |
|---|---|---|
| BDDCS (Biopharmaceutical Drug Disposition Classification System) | 2 | Benet LZ, Broccatelli F, Oprea TI |
| S (Water solubility) | 0.06 mg/mL | Benet LZ, Broccatelli F, Oprea TI |
| EoM (Fraction excreted unchanged in urine) | 0 % | Benet LZ, Broccatelli F, Oprea TI |
Predicted pharmacokinetic/toxicological properties (PK-AZ):
| Property | Description | Value | Unit | Confidence | Similarity |
|---|---|---|---|---|---|
| kinase-safety-class | ACVR2A,ACVR2B,AURKA,AXL,BRAF,BTK,CAMK2B,CAMK2D,CDK4,CDK5,CDK9,DDR1,DYRK1B,EGFR,EIF2AK3,EPHB4,ERBB2,FLT3,GRK2,GRK3,GSK3B,IKBKB,ITK,JAK1,JAK2,JAK3,MAP2K6,MAP3K21,MAP3K7,MAPK12,MAPK7,MAPK9,MAPKAPK2,MTOR,NTRK2,PDK1,PDK2,PDK4,PDPK1,PIK3CB,PIK3CG,PIM2,PLK1,PRKCD,PRKDC,SIK2,SIK3,STK33,SYK,TEK,TGFBR1,TTK,ULK1,ZAP70 | 54 | |||
| kinase-selectivity-class | ACVR2B,AXL,BRAF,CDK9,DDR1,EIF2AK3,EPHB4,GRK2,MAP2K6,SIK2,STK33,TEK | 12 | |||
| pfas-class | PFAS structural alert (1 = True, 0 = False) | 0 | |||
| pld-class | Phospholipidosis risk class (1 = positive, 0 = negative) | 0 | High | 1 |
Approvals:
| Date | Agency | Company | Orphan |
|---|---|---|---|
| Nov. 16, 2009 | FDA | ACORDA |
FDA Adverse Event Reporting System (Female)
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Application site pain | 648.67 | 13.63 | 149 | 13527 | 4571 | 90610200 |
| Application site erythema | 192.39 | 13.63 | 58 | 13618 | 5150 | 90609621 |
| Body tinea | 182.34 | 13.63 | 46 | 13630 | 2102 | 90612669 |
| Inhibitory drug interaction | 160.13 | 13.63 | 45 | 13631 | 3118 | 90611653 |
| Purpura | 159.96 | 13.63 | 66 | 13610 | 14712 | 90600059 |
| Application site burn | 156.74 | 13.63 | 35 | 13641 | 939 | 90613832 |
| Infection susceptibility increased | 154.87 | 13.63 | 46 | 13630 | 3880 | 90610891 |
| Bone density decreased | 146.55 | 13.63 | 65 | 13611 | 17280 | 90597491 |
| Glucose tolerance impaired | 122.82 | 13.63 | 46 | 13630 | 7939 | 90606832 |
| Poor quality sleep | 121.84 | 13.63 | 64 | 13612 | 24629 | 90590142 |
| Application site vesicles | 111.67 | 13.63 | 29 | 13647 | 1488 | 90613283 |
| Skin disorder | 105.70 | 13.63 | 67 | 13609 | 36639 | 90578132 |
| Impaired work ability | 103.71 | 13.63 | 53 | 13623 | 19273 | 90595498 |
| Impaired quality of life | 102.98 | 13.63 | 56 | 13620 | 23088 | 90591683 |
| Occupational exposure to product | 92.66 | 13.63 | 28 | 13648 | 2503 | 90612268 |
| Hyperlipidaemia | 84.44 | 13.63 | 49 | 13627 | 22867 | 90591904 |
| Oral herpes | 71.98 | 13.63 | 51 | 13625 | 33473 | 90581298 |
| Carbuncle | 66.23 | 13.63 | 19 | 13657 | 1417 | 90613354 |
| Blood pressure systolic abnormal | 62.24 | 13.63 | 38 | 13638 | 19440 | 90595331 |
| Pigmentation disorder | 59.09 | 13.63 | 25 | 13651 | 5924 | 90608847 |
| Monoclonal immunoglobulin present | 58.90 | 13.63 | 19 | 13657 | 2105 | 90612666 |
| Hypothalamo-pituitary disorder | 57.80 | 13.63 | 19 | 13657 | 2233 | 90612538 |
| Blood pressure systolic increased | 56.49 | 13.63 | 56 | 13620 | 58289 | 90556482 |
| Application site warmth | 56.14 | 13.63 | 12 | 13664 | 261 | 90614510 |
| Burning sensation | 56.14 | 13.63 | 58 | 13618 | 63394 | 90551377 |
| Burns second degree | 56.08 | 13.63 | 18 | 13658 | 1962 | 90612809 |
| Cataract | 55.14 | 13.63 | 61 | 13615 | 72031 | 90542740 |
| Application site hyperaesthesia | 54.60 | 13.63 | 7 | 13669 | 0 | 90614771 |
| Urticaria thermal | 53.20 | 13.63 | 13 | 13663 | 520 | 90614251 |
| Renal cyst | 48.52 | 13.63 | 28 | 13648 | 12922 | 90601849 |
| Fibrosis | 46.10 | 13.63 | 21 | 13655 | 5931 | 90608840 |
| Administration site erythema | 41.80 | 13.63 | 12 | 13664 | 897 | 90613874 |
| Immune thrombocytopenia | 40.04 | 13.63 | 25 | 13651 | 13301 | 90601470 |
| Overweight | 39.95 | 13.63 | 19 | 13657 | 5915 | 90608856 |
| Blood pressure diastolic abnormal | 39.82 | 13.63 | 29 | 13647 | 19852 | 90594919 |
| Cellulitis | 37.77 | 13.63 | 57 | 13619 | 91280 | 90523491 |
| Wrist deformity | 36.86 | 13.63 | 15 | 13661 | 3223 | 90611548 |
| Herpes zoster | 36.24 | 13.63 | 57 | 13619 | 94587 | 90520184 |
| Limb injury | 35.72 | 13.63 | 33 | 13643 | 31475 | 90583296 |
| Weight increased | 33.34 | 13.63 | 138 | 13538 | 417789 | 90196982 |
| Dyslipidaemia | 33.01 | 13.63 | 20 | 13656 | 10087 | 90604684 |
| Application site discolouration | 32.72 | 13.63 | 10 | 13666 | 928 | 90613843 |
| Movement disorder | 32.13 | 13.63 | 30 | 13646 | 28989 | 90585782 |
| Burns first degree | 32.07 | 13.63 | 5 | 13671 | 15 | 90614756 |
| Nephropathy | 32.04 | 13.63 | 19 | 13657 | 9216 | 90605555 |
| Application site swelling | 31.81 | 13.63 | 9 | 13667 | 638 | 90614133 |
| Dyschromatopsia | 30.42 | 13.63 | 9 | 13667 | 748 | 90614023 |
| Body height decreased | 29.94 | 13.63 | 20 | 13656 | 11929 | 90602842 |
| Application site oedema | 28.13 | 13.63 | 5 | 13671 | 39 | 90614732 |
| Nail bed tenderness | 26.73 | 13.63 | 7 | 13669 | 371 | 90614400 |
| Systemic lupus erythematosus | 26.06 | 13.63 | 11 | 13665 | 361885 | 90252886 |
| Scratch | 25.90 | 13.63 | 17 | 13659 | 9849 | 90604922 |
| Application site discomfort | 25.71 | 13.63 | 7 | 13669 | 431 | 90614340 |
| Blood pressure increased | 25.09 | 13.63 | 76 | 13600 | 197141 | 90417630 |
| Blood viscosity abnormal | 24.67 | 13.63 | 6 | 13670 | 235 | 90614536 |
| Metamorphopsia | 24.63 | 13.63 | 9 | 13667 | 1448 | 90613323 |
| Toxicity to various agents | 23.71 | 13.63 | 7 | 13669 | 287839 | 90326932 |
| Application site hypoaesthesia | 23.40 | 13.63 | 3 | 13673 | 0 | 90614771 |
| Complement factor C4 decreased | 23.31 | 13.63 | 6 | 13670 | 297 | 90614474 |
| Contusion | 23.27 | 13.63 | 87 | 13589 | 251129 | 90363642 |
| Dizziness postural | 22.31 | 13.63 | 15 | 13661 | 9038 | 90605733 |
| Blood iron increased | 22.04 | 13.63 | 9 | 13667 | 1950 | 90612821 |
| Pemphigus | 21.87 | 13.63 | 11 | 13665 | 326853 | 90287918 |
| Thermal burn | 21.11 | 13.63 | 13 | 13663 | 6749 | 90608022 |
| Skin plaque | 21.00 | 13.63 | 15 | 13661 | 9960 | 90604811 |
| Throat irritation | 20.99 | 13.63 | 31 | 13645 | 48664 | 90566107 |
| Migraine with aura | 20.69 | 13.63 | 10 | 13666 | 3226 | 90611545 |
| Dysstasia | 20.54 | 13.63 | 22 | 13654 | 25030 | 90589741 |
| Vitamin B12 deficiency | 19.89 | 13.63 | 13 | 13663 | 7473 | 90607298 |
| Hepatic steatosis | 19.63 | 13.63 | 26 | 13650 | 36919 | 90577852 |
| Application site necrosis | 19.50 | 13.63 | 3 | 13673 | 8 | 90614763 |
| Blood pressure fluctuation | 19.27 | 13.63 | 31 | 13645 | 52382 | 90562389 |
| Wound | 19.09 | 13.63 | 11 | 13665 | 302969 | 90311802 |
| Hypertension | 18.96 | 13.63 | 126 | 13550 | 457406 | 90157365 |
| Heart rate decreased | 18.80 | 13.63 | 31 | 13645 | 53474 | 90561297 |
| Therapy non-responder | 18.63 | 13.63 | 54 | 13622 | 136650 | 90478121 |
| Glossodynia | 18.47 | 13.63 | 13 | 13663 | 321766 | 90293005 |
| Illness | 18.18 | 13.63 | 39 | 13637 | 81930 | 90532841 |
| Application site pruritus | 18.12 | 13.63 | 10 | 13666 | 4237 | 90610534 |
| Autonomic neuropathy | 17.59 | 13.63 | 7 | 13669 | 1420 | 90613351 |
| Cryoglobulinaemia | 17.49 | 13.63 | 6 | 13670 | 804 | 90613967 |
| Insomnia | 17.06 | 13.63 | 97 | 13579 | 333377 | 90281394 |
| Hand deformity | 16.97 | 13.63 | 12 | 13664 | 296350 | 90318421 |
| Secretion discharge | 16.77 | 13.63 | 16 | 13660 | 15880 | 90598891 |
| Urticaria contact | 16.60 | 13.63 | 3 | 13673 | 26 | 90614745 |
| Application site rash | 16.32 | 13.63 | 8 | 13668 | 2661 | 90612110 |
| Gastrointestinal procedural complication | 16.23 | 13.63 | 5 | 13671 | 477 | 90614294 |
| Application site haematoma | 16.21 | 13.63 | 3 | 13673 | 30 | 90614741 |
| Back pain | 16.05 | 13.63 | 92 | 13584 | 317083 | 90297688 |
| Joint stiffness | 16.02 | 13.63 | 36 | 13640 | 78006 | 90536765 |
| Vulvovaginal pruritus | 15.94 | 13.63 | 9 | 13667 | 3984 | 90610787 |
| Finger deformity | 15.73 | 13.63 | 22 | 13654 | 32875 | 90581896 |
| Cough | 15.51 | 13.63 | 102 | 13574 | 368860 | 90245911 |
| Burning mouth syndrome | 15.12 | 13.63 | 5 | 13671 | 598 | 90614173 |
| Oropharyngeal discomfort | 14.85 | 13.63 | 11 | 13665 | 7724 | 90607047 |
| Anti-cyclic citrullinated peptide antibody positive | 14.31 | 13.63 | 9 | 13667 | 236424 | 90378347 |
| Product preparation issue | 14.25 | 13.63 | 7 | 13669 | 2339 | 90612432 |
| Oxygen saturation decreased | 14.21 | 13.63 | 42 | 13634 | 107441 | 90507330 |
| Pericarditis | 14.12 | 13.63 | 12 | 13664 | 270139 | 90344632 |
| Dysuria | 14.07 | 13.63 | 23 | 13653 | 39378 | 90575393 |
| Myalgia | 14.06 | 13.63 | 58 | 13618 | 175067 | 90439704 |
| Skin burning sensation | 13.97 | 13.63 | 16 | 13660 | 19595 | 90595176 |
| Heart rate increased | 13.87 | 13.63 | 43 | 13633 | 112859 | 90501912 |
| Vulvovaginal swelling | 13.77 | 13.63 | 5 | 13671 | 791 | 90613980 |
FDA Adverse Event Reporting System (Male)
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Application site pain | 735.96 | 17.24 | 137 | 4223 | 2192 | 42614783 |
| Application site erythema | 166.55 | 17.24 | 41 | 4319 | 2525 | 42614450 |
| Burning sensation | 109.75 | 17.24 | 50 | 4310 | 20963 | 42596012 |
| Application site vesicles | 60.32 | 17.24 | 14 | 4346 | 668 | 42616307 |
| Sleep deficit | 45.79 | 17.24 | 12 | 4348 | 947 | 42616028 |
| Application site burn | 44.44 | 17.24 | 9 | 4351 | 224 | 42616751 |
| Application site warmth | 38.59 | 17.24 | 5 | 4355 | 3 | 42616972 |
| Quality of life decreased | 38.51 | 17.24 | 16 | 4344 | 5360 | 42611615 |
| Hyperaesthesia | 33.70 | 17.24 | 15 | 4345 | 5937 | 42611038 |
| Child abuse | 32.42 | 17.24 | 9 | 4351 | 883 | 42616092 |
| Application site discomfort | 31.48 | 17.24 | 6 | 4354 | 108 | 42616867 |
| Application site necrosis | 30.52 | 17.24 | 4 | 4356 | 3 | 42616972 |
| Epidural lipomatosis | 30.14 | 17.24 | 10 | 4350 | 1790 | 42615185 |
| Application site swelling | 30.09 | 17.24 | 7 | 4353 | 337 | 42616638 |
| Victim of child abuse | 29.87 | 17.24 | 9 | 4351 | 1180 | 42615795 |
| Pain | 29.33 | 17.24 | 72 | 4288 | 244776 | 42372199 |
| Drug ineffective | 29.08 | 17.24 | 134 | 4226 | 630063 | 41986912 |
| Application site paraesthesia | 27.74 | 17.24 | 4 | 4356 | 10 | 42616965 |
| Juvenile idiopathic arthritis | 26.40 | 17.24 | 10 | 4350 | 2629 | 42614346 |
| Glaucoma | 26.19 | 17.24 | 14 | 4346 | 8234 | 42608741 |
| Anticholinergic syndrome | 23.34 | 17.24 | 8 | 4352 | 1581 | 42615394 |
| Drug eruption | 20.96 | 17.24 | 18 | 4342 | 23057 | 42593918 |
| Swollen tongue | 20.18 | 17.24 | 17 | 4343 | 21214 | 42595761 |
| Osteoarthritis | 20.08 | 17.24 | 18 | 4342 | 24387 | 42592588 |
| Application site ulcer | 18.88 | 17.24 | 3 | 4357 | 17 | 42616958 |
| Inappropriate schedule of product administration | 18.14 | 17.24 | 34 | 4326 | 95868 | 42521107 |
| Electric shock sensation | 18.09 | 17.24 | 5 | 4355 | 483 | 42616492 |
| Tenderness | 17.35 | 17.24 | 11 | 4349 | 8872 | 42608103 |
FDA Adverse Event Reporting System (Geriatric)
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Application site pain | 878.75 | 15.11 | 193 | 15004 | 5306 | 110568796 |
| Application site erythema | 269.28 | 15.11 | 75 | 15122 | 5535 | 110568567 |
| Body tinea | 182.26 | 15.11 | 45 | 15152 | 2070 | 110572032 |
| Application site burn | 169.60 | 15.11 | 37 | 15160 | 980 | 110573122 |
| Bone density decreased | 153.91 | 15.11 | 64 | 15133 | 15978 | 110558124 |
| Infection susceptibility increased | 149.63 | 15.11 | 45 | 15152 | 4353 | 110569749 |
| Inhibitory drug interaction | 140.23 | 15.11 | 44 | 15153 | 4903 | 110569199 |
| Purpura | 134.18 | 15.11 | 66 | 15131 | 24322 | 110549780 |
| Application site vesicles | 133.37 | 15.11 | 33 | 15164 | 1531 | 110572571 |
| Glucose tolerance impaired | 117.67 | 15.11 | 46 | 15151 | 9791 | 110564311 |
| Poor quality sleep | 114.14 | 15.11 | 62 | 15135 | 28015 | 110546087 |
| Skin disorder | 104.29 | 15.11 | 68 | 15129 | 42845 | 110531257 |
| Impaired work ability | 98.21 | 15.11 | 55 | 15142 | 26364 | 110547738 |
| Impaired quality of life | 91.68 | 15.11 | 55 | 15142 | 29962 | 110544140 |
| Application site warmth | 79.54 | 15.11 | 16 | 15181 | 282 | 110573820 |
| Hyperlipidaemia | 75.55 | 15.11 | 52 | 15145 | 35796 | 110538306 |
| Burning sensation | 75.38 | 15.11 | 68 | 15129 | 69144 | 110504958 |
| Oral herpes | 68.27 | 15.11 | 49 | 15148 | 36031 | 110538071 |
| Carbuncle | 67.59 | 15.11 | 19 | 15178 | 1448 | 110572654 |
| Blood pressure systolic abnormal | 64.36 | 15.11 | 41 | 15156 | 24809 | 110549293 |
| Application site hyperaesthesia | 63.14 | 15.11 | 8 | 15189 | 0 | 110574102 |
| Blood pressure systolic increased | 57.89 | 15.11 | 64 | 15133 | 82927 | 110491175 |
| Monoclonal immunoglobulin present | 57.30 | 15.11 | 19 | 15178 | 2521 | 110571581 |
| Hypothalamo-pituitary disorder | 55.18 | 15.11 | 19 | 15178 | 2827 | 110571275 |
| Urticaria thermal | 54.45 | 15.11 | 13 | 15184 | 518 | 110573584 |
| Cataract | 53.21 | 15.11 | 60 | 15137 | 79425 | 110494677 |
| Administration site erythema | 51.58 | 15.11 | 12 | 15185 | 427 | 110573675 |
| Pigmentation disorder | 50.03 | 15.11 | 23 | 15174 | 7288 | 110566814 |
| Occupational exposure to product | 48.55 | 15.11 | 13 | 15184 | 826 | 110573276 |
| Application site swelling | 47.83 | 15.11 | 13 | 15184 | 874 | 110573228 |
| Application site paraesthesia | 43.53 | 15.11 | 8 | 15189 | 85 | 110574017 |
| Herpes zoster | 42.83 | 15.11 | 63 | 15134 | 108316 | 110465786 |
| Burns second degree | 42.74 | 15.11 | 21 | 15176 | 7712 | 110566390 |
| Blood pressure diastolic abnormal | 41.96 | 15.11 | 32 | 15165 | 25783 | 110548319 |
| Blood pressure increased | 41.29 | 15.11 | 102 | 15095 | 258271 | 110315831 |
| Overweight | 40.09 | 15.11 | 19 | 15178 | 6445 | 110567657 |
| Renal cyst | 39.80 | 15.11 | 27 | 15170 | 18145 | 110555957 |
| Wrist deformity | 38.44 | 15.11 | 15 | 15182 | 3174 | 110570928 |
| Cellulitis | 38.37 | 15.11 | 65 | 15132 | 125951 | 110448151 |
| Fibrosis | 37.08 | 15.11 | 19 | 15178 | 7623 | 110566479 |
| Weight increased | 36.84 | 15.11 | 134 | 15063 | 419510 | 110154592 |
| Application site discomfort | 36.36 | 15.11 | 9 | 15188 | 418 | 110573684 |
| Limb injury | 35.23 | 15.11 | 34 | 15163 | 37602 | 110536500 |
| Sleep deficit | 34.89 | 15.11 | 12 | 15185 | 1780 | 110572322 |
| Application site necrosis | 34.32 | 15.11 | 5 | 15192 | 9 | 110574093 |
| Movement disorder | 34.29 | 15.11 | 33 | 15164 | 36371 | 110537731 |
| Body height decreased | 33.93 | 15.11 | 20 | 15177 | 10543 | 110563559 |
| Application site discolouration | 32.54 | 15.11 | 10 | 15187 | 1039 | 110573063 |
| Application site oedema | 31.90 | 15.11 | 6 | 15191 | 73 | 110574029 |
| Immune thrombocytopenia | 30.37 | 15.11 | 25 | 15172 | 22469 | 110551633 |
| Child abuse | 29.82 | 15.11 | 9 | 15188 | 880 | 110573222 |
| Burns first degree | 29.33 | 15.11 | 5 | 15192 | 33 | 110574069 |
| Toxicity to various agents | 28.89 | 15.11 | 15 | 15182 | 480540 | 110093562 |
| Dyslipidaemia | 28.64 | 15.11 | 21 | 15176 | 15944 | 110558158 |
| Contusion | 28.09 | 15.11 | 83 | 15114 | 233278 | 110340824 |
| Application site hypoaesthesia | 27.91 | 15.11 | 4 | 15193 | 6 | 110574096 |
| Hyperaesthesia | 27.85 | 15.11 | 20 | 15177 | 14707 | 110559395 |
| General physical health deterioration | 27.52 | 15.11 | 12 | 15185 | 425283 | 110148819 |
| Nail bed tenderness | 27.27 | 15.11 | 7 | 15190 | 377 | 110573725 |
| Nephropathy | 27.11 | 15.11 | 19 | 15178 | 13448 | 110560654 |
| Victim of child abuse | 27.08 | 15.11 | 9 | 15188 | 1202 | 110572900 |
| Dyschromatopsia | 26.50 | 15.11 | 9 | 15188 | 1285 | 110572817 |
| Quality of life decreased | 26.24 | 15.11 | 19 | 15178 | 14150 | 110559952 |
| Therapy non-responder | 26.06 | 15.11 | 63 | 15134 | 157244 | 110416858 |
| Epidural lipomatosis | 25.90 | 15.11 | 10 | 15187 | 2057 | 110572045 |
| Blood iron increased | 25.30 | 15.11 | 10 | 15187 | 2188 | 110571914 |
| Blood viscosity abnormal | 24.80 | 15.11 | 6 | 15191 | 253 | 110573849 |
| Metamorphopsia | 24.45 | 15.11 | 9 | 15188 | 1624 | 110572478 |
| Insomnia | 24.26 | 15.11 | 106 | 15091 | 360484 | 110213618 |
| Pain | 24.13 | 15.11 | 218 | 14979 | 954737 | 109619365 |
| Complement factor C4 decreased | 22.79 | 15.11 | 6 | 15191 | 357 | 110573745 |
| Allodynia | 22.32 | 15.11 | 9 | 15188 | 2074 | 110572028 |
| Inappropriate schedule of product administration | 21.31 | 15.11 | 69 | 15128 | 203568 | 110370534 |
| Scratch | 20.89 | 15.11 | 16 | 15181 | 12963 | 110561139 |
| Dysstasia | 20.55 | 15.11 | 24 | 15173 | 32962 | 110541140 |
| Heart rate decreased | 20.46 | 15.11 | 39 | 15158 | 82717 | 110491385 |
| Thermal burn | 20.24 | 15.11 | 13 | 15184 | 7975 | 110566127 |
| Skin plaque | 19.08 | 15.11 | 15 | 15182 | 12630 | 110561472 |
| Finger deformity | 18.84 | 15.11 | 23 | 15174 | 33069 | 110541033 |
| Nasopharyngitis | 18.73 | 15.11 | 105 | 15092 | 394256 | 110179846 |
| Vulvovaginal pruritus | 18.27 | 15.11 | 9 | 15188 | 3322 | 110570780 |
| Illness | 18.23 | 15.11 | 37 | 15160 | 82134 | 110491968 |
| Migraine with aura | 17.87 | 15.11 | 9 | 15188 | 3483 | 110570619 |
| Vitamin B12 deficiency | 17.53 | 15.11 | 13 | 15184 | 10042 | 110564060 |
| Dizziness postural | 17.18 | 15.11 | 15 | 15182 | 14594 | 110559508 |
| Myalgia | 17.00 | 15.11 | 68 | 15129 | 222313 | 110351789 |
| Urticaria contact | 16.88 | 15.11 | 3 | 15194 | 26 | 110574076 |
| Gastrointestinal procedural complication | 16.86 | 15.11 | 5 | 15192 | 460 | 110573642 |
| Drug ineffective | 16.65 | 15.11 | 297 | 14900 | 1520243 | 109053859 |
| Application site exfoliation | 15.86 | 15.11 | 5 | 15192 | 565 | 110573537 |
| Back pain | 15.81 | 15.11 | 96 | 15101 | 370900 | 110203202 |
| Juvenile idiopathic arthritis | 15.77 | 15.11 | 10 | 15187 | 5997 | 110568105 |
| Fatigue | 15.67 | 15.11 | 244 | 14953 | 1215714 | 109358388 |
| Vulvovaginal swelling | 15.50 | 15.11 | 5 | 15192 | 608 | 110573494 |
| Cryoglobulinaemia | 15.36 | 15.11 | 6 | 15191 | 1273 | 110572829 |
| Lip swelling | 15.23 | 15.11 | 26 | 15171 | 50641 | 110523461 |
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| ATC | M02AB01 | MUSCULO-SKELETAL SYSTEM TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN Capsaicin and similar agents |
| ATC | N01BX04 | NERVOUS SYSTEM ANESTHETICS ANESTHETICS, LOCAL Other local anesthetics |
| CHEBI has role | CHEBI:35480 | analgesic |
| CHEBI has role | CHEBI:35481 | non-narcotic analgesic |
| CHEBI has role | CHEBI:35554 | cardiovascular drug |
| CHEBI has role | CHEBI:35610 | antineoplastic agent |
| CHEBI has role | CHEBI:35674 | antihypertensive agent |
| CHEBI has role | CHEBI:38634 | voltage-gated sodium channel blocker |
| CHEBI has role | CHEBI:50919 | antiemetic |
| CHEBI has role | CHEBI:51177 | antitussive |
| CHEBI has role | CHEBI:63726 | neuroprotective agent |
| CHEBI has role | CHEBI:64946 | anti-HIV agent |
| CHEBI has role | CHEBI:67079 | anti-inflammatory agent |
| CHEBI has role | CHEBI:140535 | TRPV1 agonist |
| MeSH PA | D000982 | Antipruritics |
| MeSH PA | D003879 | Dermatologic Agents |
| MeSH PA | D018689 | Sensory System Agents |
Related Drugs by ATC class:
M02AB Capsaicin and similar agents 1 drug
N01BX Other local anesthetics 3 drugs
Drug Use | Suggest Off label Use Form| |View source of the data|
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Postherpetic neuralgia | indication | 2177002 | |
| Neuralgia | indication | 16269008 | |
| Backache | indication | 161891005 | |
| Arthritic Pain | indication | ||
| Sprains and Strains | indication | ||
| Cannabis hyperemesis syndrome co-occurrent and due to cannabis abuse | off-label use | 11047881000119100 | |
| Cannabis hyperemesis syndrome co-occurrent and due to cannabis dependence | off-label use | 11048011000119100 | |
| Gastritis | contraindication | 4556007 | DOID:4029 |
| Bacterial septicemia | contraindication | 10001005 | DOID:0040085 |
| Myocardial infarction | contraindication | 22298006 | DOID:5844 |
| Shock | contraindication | 27942005 | |
| Hypertensive disorder | contraindication | 38341003 | DOID:10763 |
| Gastrointestinal ulcer | contraindication | 40845000 | |
| Body fluid retention | contraindication | 43498006 | |
| Conduction disorder of the heart | contraindication | 44808001 | |
| Disorder of cardiovascular system | contraindication | 49601007 | DOID:1287 |
| Vitamin K deficiency | contraindication | 52675005 | DOID:11249 |
| Nasal polyp | contraindication | 52756005 | |
| Hepatic failure | contraindication | 59927004 | |
| Blood coagulation disorder | contraindication | 64779008 | DOID:1247 |
| Diabetes mellitus | contraindication | 73211009 | DOID:9351 |
| Factor II deficiency | contraindication | 73975000 | |
| Gastrointestinal hemorrhage | contraindication | 74474003 | |
| Thrombotic thrombocytopenic purpura | contraindication | 78129009 | DOID:10772 |
| Decreased respiratory function | contraindication | 80954004 | |
| Kidney disease | contraindication | 90708001 | DOID:557 |
| Thyrotoxicosis | contraindication | 90739004 | DOID:7997 |
| Hemophilia | contraindication | 90935002 | |
| Disorder of skin | contraindication | 95320005 | DOID:37 |
| Anemia due to enzyme deficiency | contraindication | 111577008 | |
| Open wound | contraindication | 125643001 | |
| Seizure disorder | contraindication | 128613002 | |
| Cerebrovascular accident | contraindication | 230690007 | |
| Heart block | contraindication | 233916004 | |
| Gastroesophageal reflux disease | contraindication | 235595009 | DOID:8534 |
| Disease of liver | contraindication | 235856003 | DOID:409 |
| Anemia | contraindication | 271737000 | DOID:2355 |
| Pregnancy, function | contraindication | 289908002 | |
| Cardiovascular event risk | contraindication | 395112001 | |
| Breastfeeding (mother) | contraindication | 413712001 | |
| Denuded skin | contraindication | 418242004 |
🐶 Veterinary Drug Use
None
🐶 Veterinary products
None
Acid dissociation constants calculated using MoKa v3.0.0
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 8.64 | acidic |
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Transient receptor potential cation channel subfamily V member 1 | Ion channel | OPENER | Ki | 8.22 | CHEMBL | CHEMBL | |||
| Prostaglandin G/H synthase 1 | Enzyme | IC50 | 5.42 | CHEMBL | |||||
| Cytochrome P450 1A2 | Enzyme | IC50 | 5.52 | DRUG MATRIX | |||||
| Arachidonate 5-lipoxygenase | Enzyme | IC50 | 4.25 | CHEMBL | |||||
| Potassium voltage-gated channel subfamily A member 1 | Ion channel | IC50 | 4.54 | CHEMBL | |||||
| Transient receptor potential cation channel subfamily M member 8 | Ion channel | IC50 | 6 | CHEMBL | |||||
| Lysine-specific histone demethylase 1A | Enzyme | IC50 | 6.22 | CHEMBL | |||||
| Tyrosine--tRNA ligase, cytoplasmic | Enzyme | Ki | 4.38 | CHEMBL | |||||
| Transient receptor potential cation channel subfamily V member 1 | Ion channel | Ki | 5.77 | CHEMBL | |||||
| NADH-ubiquinone oxidoreductase chain 1 | Enzyme | IC50 | 4.28 | CHEMBL | |||||
| Transient receptor potential cation channel subfamily M member 8 | Ion channel | IC50 | 4.55 | CHEMBL | |||||
| Transient receptor potential cation channel subfamily V member 1 | Ion channel | ACTIVATOR | EC50 | 8 | IUPHAR | ||||
| Potassium voltage-gated channel subfamily A member 7 | Ion channel | BLOCKER | IC50 | 4.60 | IUPHAR | ||||
| Potassium voltage-gated channel subfamily A member 1 | Ion channel | BLOCKER | IC50 | 4.50 | IUPHAR | ||||
| Potassium voltage-gated channel subfamily A member 2 | Ion channel | BLOCKER | Kd | 4.40 | IUPHAR |
External reference:
| ID | Source |
|---|---|
| 4019506 | VUID |
| N0000147626 | NUI |
| D00250 | KEGG_DRUG |
| 4019506 | VANDF |
| C0006931 | UMLSCUI |
| CHEBI:3374 | CHEBI |
| 4DY | PDB_CHEM_ID |
| CHEMBL294199 | ChEMBL_ID |
| DB06774 | DRUGBANK_ID |
| D002211 | MESH_DESCRIPTOR_UI |
| 1548943 | PUBCHEM_CID |
| 2486 | IUPHAR_LIGAND_ID |
| 10145 | INN_ID |
| S07O44R1ZM | UNII |
| 1992 | RXNORM |
| 169226 | MMSL |
| 4346 | MMSL |
| 6074 | MMSL |
| 001988 | NDDF |
| 400416009 | SNOMEDCT_US |
| 95995002 | SNOMEDCT_US |
| S07O44R1ZM | INXIGHT DRUGS |
Pharmaceutical products:
| Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
|---|---|---|---|---|---|---|---|---|
| Walgreens Arthritis Pain Relief Capsaicin Analgesic | HUMAN OTC DRUG LABEL | 1 | 0363-0837 | CREAM | 1 mg | TOPICAL | OTC Monograph Drug | 14 sections |
| Walgreens Roll-On | HUMAN OTC DRUG LABEL | 1 | 0363-1065 | GEL | 0.10 g | TOPICAL | OTC Monograph Drug | 8 sections |
| Heat Pain Relief | HUMAN OTC DRUG LABEL | 1 | 0363-6263 | CREAM | 0.10 g | TOPICAL | OTC Monograph Drug | 16 sections |
| Walgreens Capsaicin Hot Patch | HUMAN OTC DRUG LABEL | 1 | 0363-6691 | PATCH | 0.25 mg | TOPICAL | OTC Monograph Drug | 13 sections |
| Walgreens Capsaicin Hot | HUMAN OTC DRUG LABEL | 1 | 0363-9113 | PATCH | 0.60 mg | TOPICAL | OTC monograph not final | 13 sections |
| CAPSAICIN HEAT PATCHES BACK AND LARGE AREAS | HUMAN OTC DRUG LABEL | 1 | 0363-9902 | PATCH | 0.03 g | TOPICAL | OTC Monograph Drug | 13 sections |
| Rugby Arthritis Pain RelievingTopical Analgesic | HUMAN OTC DRUG LABEL | 1 | 0536-1118 | CREAM | 0.75 mg | TOPICAL | OTC Monograph Drug | 15 sections |
| Rugby Capsaicin Cream | HUMAN OTC DRUG LABEL | 1 | 0536-1264 | CREAM | 0.10 g | TOPICAL | OTC Monograph Drug | 13 sections |
| Capsaicin | HUMAN OTC DRUG LABEL | 1 | 0536-2525 | CREAM | 0.25 mg | TOPICAL | OTC Monograph Drug | 14 sections |
| Advil Targeted Relief | HUMAN OTC DRUG LABEL | 4 | 0573-6555 | CREAM | 0.25 mg | TOPICAL | OTC Monograph Drug | 16 sections |
| WellPatch Warming Pain Relief | HUMAN OTC DRUG LABEL | 1 | 10742-8127 | PATCH | 25 mg | TOPICAL | OTC Monograph Drug | 10 sections |
| CAPSAICIN HEAT PATCHES PAIN RELIEF | HUMAN OTC DRUG LABEL | 1 | 11822-4210 | PATCH | 0.03 g | TOPICAL | OTC Monograph Drug | 14 sections |
| RITE AID CAPSICUM HOT | HUMAN OTC DRUG LABEL | 1 | 11822-7448 | PATCH | 0.60 mg | TOPICAL | OTC monograph not final | 12 sections |
| Capsaicin | HUMAN OTC DRUG LABEL | 1 | 11822-7884 | CREAM | 0.00 g | TOPICAL | OTC Monograph Drug | 12 sections |
| ASTRAPHARM CHILLI BRAND | HUMAN OTC DRUG LABEL | 1 | 11993-000 | PLASTER | 0.25 g | TOPICAL | OTC Monograph Drug | 14 sections |
| ASTRAPHARM CHILLI BRAND EXTERNAL MEDICATED | HUMAN OTC DRUG LABEL | 1 | 11993-001 | PLASTER | 70 mg | TOPICAL | OTC monograph not final | 13 sections |
| BLUE SPRING Foot and Leg Comfort Cream with Pain Relief | HUMAN OTC DRUG LABEL | 2 | 14448-316 | CREAM | 0.25 mg | TOPICAL | OTC Monograph Drug | 13 sections |
| Dr. OH BALM | HUMAN OTC DRUG LABEL | 3 | 17452-430 | CREAM | 0.02 g | TOPICAL | OTC monograph not final | 9 sections |
| EARTHS CARE ARTHRITIS | HUMAN OTC DRUG LABEL | 1 | 24286-1559 | CREAM | 0.10 g | TOPICAL | OTC Monograph Drug | 13 sections |
| Overtime | HUMAN OTC DRUG LABEL | 3 | 27495-008 | LOTION | 0.02 g | TOPICAL | OTC Monograph Drug | 11 sections |
| Overtime | HUMAN OTC DRUG LABEL | 3 | 27495-008 | LOTION | 0.02 g | TOPICAL | OTC Monograph Drug | 11 sections |
| Dendracin Neurodendraxcin | HUMAN OTC DRUG LABEL | 3 | 27495-014 | LOTION | 0.02 g | TOPICAL | OTC Monograph Drug | 11 sections |
| Dendracin Neurodendraxcin | HUMAN OTC DRUG LABEL | 3 | 27495-014 | LOTION | 0.02 g | TOPICAL | OTC Monograph Drug | 11 sections |
| FLANAX | HUMAN OTC DRUG LABEL | 3 | 27854-499 | LINIMENT | 0.00 g | TOPICAL | OTC Monograph Drug | 10 sections |
| LaBella Linimento Obrero | HUMAN OTC DRUG LABEL | 3 | 31774-8005 | CREAM | 0.25 mg | TOPICAL | OTC monograph not final | 11 sections |
| MEDROX | HUMAN OTC DRUG LABEL | 2 | 33261-884 | PATCH | 0.04 g | TOPICAL | OTC MONOGRAPH NOT FINAL | 8 sections |
| ASSURED PAIN RELIEF HOT PATCH | HUMAN OTC DRUG LABEL | 2 | 33992-1889 | PATCH | 8.30 mg | TOPICAL | OTC monograph not final | 11 sections |
| Assured Pain Relief Hot Menthol | HUMAN OTC DRUG LABEL | 2 | 33992-6156 | PATCH | 8.30 mg | TOPICAL | OTC monograph not final | 10 sections |
| Kanjo Natural Pain relief oil | HUMAN OTC DRUG LABEL | 1 | 35192-040 | OIL | 0.08 g | TOPICAL | OTC Monograph Drug | 8 sections |
| Capsaicin | HUMAN OTC DRUG LABEL | 1 | 36800-729 | LIQUID | 0.15 g | TOPICAL | OTC monograph not final | 7 sections |